LAZERTINIB vs LEDIPASVIR\SOFOSBUVIR: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LAZERTINIB vs LEDIPASVIR\SOFOSBUVIR: Safety Overview
| Metric | LAZERTINIB | LEDIPASVIR\SOFOSBUVIR |
|---|---|---|
| Total FAERS Reports | 352 | 23,616 |
| Deaths Reported | 15 | 1,371 |
| Death Rate | 4.3% | 5.8% |
| Hospitalizations | 83 | 4,031 |
| Average Patient Age | 66.6 yrs | 57.9 yrs |
| % Female Patients | 59.9% | 42.9% |
| FDA Approval Date | Aug 19, 2024 | N/A |
| Manufacturer | Janssen Biotech, Inc. | N/A |
| Route | ORAL | N/A |
| Marketing Status | Prescription | N/A |